Status:

ENROLLING_BY_INVITATION

Intermitent Hypoxia and Its Pathophysiology Consequences in the Sleep Apnea-Hypopnea Syndrome.

Lead Sponsor:

Alberto Alonso Fernandez

Collaborating Sponsors:

Instituto de Salud Carlos III

Conditions:

Sleep Apnea, Obstructive

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

Clinical trial on the effect of continuous positive pressure (CPAP). Objectives: 1) To assess the total or partial recovery of oxidative and inflammatory damage after recovering IH. 2) To check whethe...

Detailed Description

Design: Randomized, parallel group, non-blinded, controlled clinical trial compared with conventional treatment. A. Protocol and intervention Patients with an AHI\>30 h-1 will be assigned, using a 1:...

Eligibility Criteria

Inclusion

  • Cases: patients with AHI \> 30
  • Controls: subjects with AHI \< 5 and Epworth \>10

Exclusion

  • Epworth\>18
  • BMI\<40Kg/M2
  • Arterial Hypertension
  • Mellitus Diabetes
  • Cerebrovascular disease
  • Ischemic heart disease
  • Cardiac arrhythmia
  • Chronic cardiovascular diseases
  • Daytime Oxygen saturation\>95%
  • Risk professions (professional drivers)
  • Concomitant treatment with antihypertensives, statins, antidiabetics, beta-blockers or systemics corticosteroids.
  • Pretreatment with CPAP.
  • Participation in another clinical trial thirty days prior to randomization

Key Trial Info

Start Date :

July 20 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 6 2025

Estimated Enrollment :

130 Patients enrolled

Trial Details

Trial ID

NCT04444778

Start Date

July 20 2020

End Date

May 6 2025

Last Update

May 1 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Hospital Son Espases

Palma, Balearic Islands, Spain, 07006

2

Hospital Son Llatzer

Palma, Balearic Islands, Spain, 07006

Intermitent Hypoxia and Its Pathophysiology Consequences in the Sleep Apnea-Hypopnea Syndrome. | DecenTrialz